A
Alessandro Lucidi
Researcher at Catholic University of the Sacred Heart
Publications - 36
Citations - 611
Alessandro Lucidi is an academic researcher from Catholic University of the Sacred Heart. The author has contributed to research in topics: Cervical cancer & Medicine. The author has an hindex of 12, co-authored 28 publications receiving 486 citations. Previous affiliations of Alessandro Lucidi include University of Molise & Sapienza University of Rome.
Papers
More filters
Journal ArticleDOI
Acquisition of chemoresistance and EMT phenotype is linked with activation of the endothelin A receptor pathway in ovarian carcinoma cells
Laura Rosanò,Roberta Cianfrocca,Francesca Spinella,Valeriana Di Castro,Maria Rita Nicotra,Alessandro Lucidi,Gabriella Ferrandina,Pier Giorgio Natali,Anna Bagnato +8 more
TL;DR: The data provide the first evidence that blockade of ETAR-driven EMT can overcome chemoresistance and inhibit tumor progression, improving the outcome of EOC patients' treatment.
Journal ArticleDOI
Role of Extracellular Vesicles in Epithelial Ovarian Cancer: A Systematic Review.
Alessandro Lucidi,Danilo Buca,Carlo Ronsini,Sara Tinari,Giuseppina Bologna,D. Buca,Martina Leombroni,Marco Liberati,Francesco D'Antonio,Giovanni Scambia,Paola Lanuti,Marco Petrillo +11 more
TL;DR: The literature findings demonstrate that a panel of EV-derived circulating miRNAs may be useful for early diagnosis of EOC, and it appears clear that EVs are involved in mediating two crucial processes for metastatic and chemoresistance development: the epithelial–mesenchymal transition, and tumor escape from the immune system response.
Journal ArticleDOI
Quality of Life in Women After Pelvic Exenteration for Gynecological Malignancies: A Multicentric Study
M Dessole,Marco Petrillo,Alessandro Lucidi,Angelica Naldini,Martina Rossi,Pierandrea De Iaco,Simone Marnitz,Jalid Sehouli,Giovanni Scambia,Vito Chiantera,Vito Chiantera +10 more
TL;DR: The reduction of ostomies seems the most effective way to improve patients’ quality of life and long-term psycho-oncological support is strongly recommended.
Journal ArticleDOI
Can radicality of surgery be safely modulated on the basis of MRI and PET/CT imaging in locally advanced cervical cancer patients administered preoperative treatment?
Gabriella Ferrandina,Marco Petrillo,Gennaro Restaino,Vittoria Rufini,Gabriella Macchia,Arnaldo Carbone,Gian Franco Zannoni,Alessandro Lucidi,Giorgia D'Angelo,Giovanni Scambia +9 more
TL;DR: Diagnostic performances of magnetic resonance imaging (MRI) and positron emission tomography (PET/computed tomography) in predicting pathologically assessed residual disease in a large, single‐institution series of locally advanced cervical cancer patients triaged to neoadjuvant treatments followed by radical surgery are analyzed.
Journal ArticleDOI
Hepatoceliac Lymph Node Involvement in Advanced Ovarian Cancer Patients: Prognostic Role and Clinical Considerations.
Valerio Gallotta,Gabriella Ferrandina,Gabriella Ferrandina,Giuseppe Vizzielli,Carmine Conte,Alessandro Lucidi,Barbara Costantini,Agostino Maria De Rose,Andrea Di Giorgio,Gian Franco Zannoni,Anna Fagotti,Giovanni Scambia,Vito Chiantera +12 more
TL;DR: The study confirmed that HCLN surgery is feasible with acceptable morbidities for patients with advanced OC and confirmed that Metastatic HCLNs are a marker of disease severity associated with worst oncologic outcome.